| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ABIOMED INC | 3,150,000 | 119,889,000 | 37.42% | ||
| 2 | REVANCE THERAPEUTICS INC | 4,592,047 | 77,789,000 | 24.28% | ||
| 3 | CORIUM | 9,353,304 | 57,055,000 | 17.81% | ||
| 4 | ENDOLOGIX INC | 2,514,936 | 43,633,000 | 13.62% | ||
| 5 | ZIOPHARM Oncology, Inc. | 2,700,408 | 13,691,000 | 4.27% | ||
| 6 | ACURA PHARMACEUTICALS INC | 10,284,886 | 4,402,000 | 1.37% | ||
| 7 | MEDICINOVA INC | 1,170,370 | 3,558,000 | 1.11% | ||
| 8 | CURIS INC | 233,797 | 350,000 | 0.11% | ||
| 9 | Echo Therapeutics Inc | 12,319 | 17,000 | 0.01% | ||
| 10 | PALATIN TECHNOLOGIES INC COM PAR $ .01 | 23,928 | 17,000 | 0.01% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-15-000400, filed 2015.02.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
